Home
Who we are
Why we exist
Experts speak
Events
How to help

 



 

 

Actonel: Drug Company Keeps Data from Collaborating Scientists
Prof. Peter Saunders. Institute of Science in Society.

Watchdog eyes scientific fraud
THES: 14 April 2006

Panel to expose fraudulent medical research
The Guardian: Alexandra Smith April 12, 2006

MHRA needs to be examined next
The Independent: Letters 10 April 2006

Payout in P&G drug data row
THES: Published: 07 April 2006

Britain: Drug trial leaves volunteers seriously ill
Scientist attacks lax regulatory regime
By Chris Talbot, 29 March 2006
World Socialist Web Site

Bone researcher charges P&G with continuing data concealment
1 March 2006

Researchers to get a bill of rights from P&G
Times Higher February 24th 2006

Half hour long BBC Radio Broadcast
Vivienne Parry investigates if Proctor and Gamble attempted to boost the sales of one of its drugs by hindering independent scientific research (23 Feb 2006).

Experts cast doubt over scientists' claims for Actonel
Times Higher Published: 24 February 2006

Efficacy of Osteoporosis Medicine Challenged
by Richard Harris (NPR Radio, USA)
A British scientist has been in the United States this week alleging that a big drugmaker has been playing fast and loose with data to make its medicine look good. The drug in question is Actonel, used for treating osteoporosis and a big earner for Procter & Gamble.
Audio at:


Scientist Presses Claim P&G Misrepresented Actonel Data
By SARAH ELLISON, February 23, 2006
The Wall Street Journal

Interview Radio New Zealand (23 minutes)

09:26 Drug Companies (duration: 23'11?)
Aubrey Blumsohn, Suspended bone metabolism expert on Drug Companies.

Data row sparks research debate
Times Higher Education Supplement 25 Nov 05

When access to data is a real bone of contention
Times Higher Education Supplement 25 Nov 05

Doctor accuses drugs giant of 'unethical' secrecy
(Observer 4th December)

How the drugs giant and a lone academic went to war
(Observer 4th December)

Journals reject tougher checks on data
THES: Published: 20 January 2006

Journal warned about P&G data, THES 09 December 2005

MP calls for probe into Sheffield's relationship with the drug industry
THES 16 December 2005

Correspondence in Observer 11 Dec 2005

Whistleblower wins drugs study inquiry, Observer 11 Dec 05

Gag money rejected, THES 16 Dec 05

Rent-a-Researcher
Did a British university sell out to Procter & Gamble?
Slate, Dec 22 05

British scientist challenges pharmaceutical company over
research paper
By Chris Talbot, World Socialist Web Site, 28 January 2006

Doctor in drug research row quits NHS post
Jo Revill, Sunday January 15, 2006
The Observer

Researchers to get a bill of rights from P&G
THES February 24th 2006

Efficacy of Osteoporosis Medicine Challenged
by Richard Harris (NPR Radio, USA)
A Sheffield scientist has been in the United States this week alleging that a big drugmaker has been playing fast and loose with data to make its medicine look good. The drug in question is Actonel, used for treating osteoporosis and a big earner for Procter & Gamble.
Audio at: